Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.04M Sell
23,796
-35,112
-60% -$1.57M 0.05% 379
2019
Q2
$2.94M Buy
58,908
+13,203
+29% +$556K 0.16% 173
2019
Q1
$1.76M Buy
45,705
+44
+0.1% +$1.59K 0.09% 248
2018
Q4
$1.36M Buy
+45,661
New +$1.44M 0.08% 262

Other funds holding BRKR

Boston Advisors's BRKR Position: Q3 2019 in Review

Boston Advisors reduced its Bruker (BRKR) stake by 60% in Q3 2019, selling an estimated $1.57M and leaving 23,796 shares worth $1.04M. The position accounts for 0.05% of the portfolio, ranked #379.

Boston Advisors first reported a position in BRKR in Q4 2018 and has held it in 4 quarters since. The position peaked at $2.94M in Q2 2019. 249 funds tracked by Wall St. Rank hold BRKR as of Q3 2019.

  • Boston Advisors held 23,796 shares of Bruker worth $1.04M as of Q3 2019.
  • Boston Advisors sold 35,112 Bruker shares in Q3 2019, an estimated $1.57M.
  • Bruker made up 0.05% of Boston Advisors's portfolio in Q3 2019, its #379 holding.
  • Boston Advisors first reported a position in Bruker in Q4 2018 and has held it in 4 quarters since.
  • Boston Advisors's Bruker position peaked at $2.94M in Q2 2019.
  • 249 funds tracked by Wall St. Rank held Bruker as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.